Google affiliate scraps plan for Toronto smart city project

Google affiliate scraps plan for Toronto smart city project

TORONTO (AP) — Google abandoned its smart-city development in Toronto on Thursday after more than two years of controversy over privacy concerns and amid economic uncertainty caused by the pandemic. A unit of Google’s parent company Alphabet had been proposing to turn...
US consumer borrowing fell for first time since 2011

US consumer borrowing fell for first time since 2011

WASHINGTON (AP) — U.S. consumer borrowing fell in March for the first time in more than eight years, with the category covering credit cards dropping by the largest amount in over three decades, the Federal Reserve reported Thursday.The Fed’s report is the...
Republican donor, fundraiser DeJoy next postmaster general

Republican donor, fundraiser DeJoy next postmaster general

RALEIGH, N.C. (AP) — A Republican fundraiser and prolific political donor from North Carolina will be the next postmaster general.Louis DeJoy of Greensboro, a close ally of President Donald Trump, was the unanimous pick of the U.S. Postal Service’s Board of...
US faces ‘truly daunting’ challenges on needed COVID tests

US faces ‘truly daunting’ challenges on needed COVID tests

WASHINGTON (AP) — Despite a massive effort, the nation faces “truly daunting” challenges to deploy millions of coronavirus tests to safely re-open the economy, the head of the National Institutes of Health told lawmakers Thursday.NIH Director Francis Collins told the...
Uber loses $2.9 billion, offloads bike and scooter business

Uber loses $2.9 billion, offloads bike and scooter business

NEW YORK (AP) — Uber lost $2.9 billion in the first quarter as its overseas investments were hammered by the coronavirus pandemic, but the company is looking to its growing food delivery business and aggressive cost-cutting to ease the pain.The ride-hailing giant said...
Malaria drug shows no benefit in another coronavirus study

Malaria drug shows no benefit in another coronavirus study

A new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection.Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 patients treated at Columbia...